“Biosimilars offer significant value to patients, providers and payers, increasing the number of treatment options available to patients across many disease areas at a reduced cost to the healthcare system. The Justices’ unanimous ruling on the notice…
Sandoz is seeking approval for their proposed biosimilars adalimumab and infliximab for use in all indications of their respective reference medicines, Humira®* and Remicade®†Comprehensive data packages demonstrate each biosimilar matches its respectiv…
Building depth across key therapeutic areas with 12 potential blockbusters in late stage development and 40 potential filings in US and EU between 2017-2020Focused and taking steps to become stronger and more integrated through centralized manufacturin…
Building depth across key therapeutic areas with 12 potential blockbusters in late stage development and 40 potential filings in US and EU between 2017-2020Focused and taking steps to become stronger and more integrated through centralized manufacturin…
Net sales grew 2% (cc, -1% USD), as growth drivers more than offset Gleevec/Glivec impactCosentyx (USD 410 million, +136% cc) showing strong growth in all three indicationsEntresto (USD 84 million) steadily growing with better access in US and EUGileny…
Sandoz receives positive CHMP opinions for biosimilars rituximab and etanercept to treat immunological diseases. Biosimilar rituximab also recommended to treat blood cancersComprehensive data packages, confirming Sandoz biosimilars rituximab and etane…
Total investment of EUR 105 million in Prevalje site reinforces commitment to largest Sandoz business, Anti-Infectives, and single largest global product, broad-spectrum antibiotic amoxicillin-clavulanic acid.The investment will bring 150 new jobs, mor…
Sandoz Scientific Standalone event — “Reach Targets, Save Lives” – aims at increasing access to information in the field of cardiovascular therapies in Central & Eastern Europe and Middle East & Africa (CEEMEA)Lectures by leading cardiologists…
Sandoz Scientific Standalone event — “Reach Targets, Save Lives” – aims at increasing access to information in the field of cardiovascular therapies in Central & Eastern Europe and Middle East & Africa (CEEMEA)Lectures by leading cardiologists…
Three winners, chosen by expert panel at Wired Health 2017 in London, identified innovative approaches to address access challenges in Ghana, the Maldives and the Philippines. Winning ideas proposed novel ways to use mobile technologies to connect pa…